Pihlajalinna

9,43EUR -0,74 %
8.545 investorer følger denne virksomhed

Pihlajalinna operates in the health care sector. A number of health centers, hospitals, dental clinics, and specialist care are operated within the Group. Through its own hospitals, collaboration takes place with a number of companies in the insurance industry, and specialist expertise is found in a number of work areas such as gynecology, plastic surgery, and orthopedics. The company was founded in 2001 and is headquartered in Tampere.

P/E (23e)
17,18
EV/EBIT (23e)
17,4
P/B (23e)
1,35
Udbytteafkast, % (23e)
2,12 %
Kursmål
9.50 EUR
Anbefaling
Reducer
Opdateret
29.5.2023
NASDAQ Helsinki
PIHLIS
Daglig lav / høj pris
9,26 / 9,43 EUR
Markedsværdi
213,31 mio. EUR
Aktieomsætning
4,45 t EUR
Volumen
476
Risiko og anbefaling
HøjRisikoLav
SælgAnbefalingKøb

Resultatopgørelse

20192020202120222023e2024e2025e2026e
Omsætning518,60508,65577,70690,32742,31781,99823,70848,09
vækst-%6,31 %-1,92 %13,58 %19,49 %7,53 %5,35 %5,33 %2,96 %
EBITDA47,8652,5163,0054,4483,1784,3888,2091,30
EBIT (adj.)20,7621,1130,4018,5830,6735,6740,9044,15
EBIT10,1618,2128,008,9831,3734,8740,1043,35
Overskud før skat6,2613,8124,161,5820,2725,4231,1934,74
Netto indkomst3,388,8320,069,5813,0816,5721,3425,74
EPS (adj.)0,620,520,990,850,550,770,981,18
vækst-%200,97 %-16,10 %91,72 %-14,43 %-35,47 %40,37 %27,45 %19,85 %
Udbytte0,000,200,300,000,200,300,400,40
Udbytte ratio51,25 %33,79 %34,48 %40,81 %42,26 %35,04 %

Profitability and return on capital

20192020202120222023e2024e2025e2026e
EBITDA-%9,23 %10,32 %10,91 %7,89 %11,20 %10,79 %10,71 %10,77 %
EBIT-% (adj.)4,00 %4,15 %5,26 %2,69 %4,13 %4,56 %4,96 %5,21 %
EBIT-%1,96 %3,58 %4,85 %1,30 %4,23 %4,46 %4,87 %5,11 %
ROE3,04 %8,38 %17,54 %7,88 %9,31 %10,16 %12,10 %14,14 %
ROI3,10 %5,61 %8,69 %2,13 %6,11 %6,98 %8,12 %8,87 %

Værdiansættelse

20192020202120222023e2024e2025e2026e
Share price (EUR)15,289,3812,648,529,439,439,439,43
Aktier22,6222,6222,5922,5522,5522,5522,5522,55
Markedsværdi345,64212,15285,59192,12212,64212,64212,64212,64
Enterprise value539,74406,95480,29579,62545,93526,44505,68504,21
EV/S1,040,800,830,840,740,670,610,59
EV/EBITDA11,287,757,6210,656,566,245,735,52
EV/EBIT (adj.)26,0019,2815,8031,1917,8014,7612,3711,42
EV/EBIT53,1222,3517,1564,5417,4015,1012,6111,63
P/E (adj.)24,7218,0912,7210,0217,1812,249,608,01
P/E102,2624,0314,2420,0516,2612,839,968,26
P/B3,421,932,401,551,351,261,161,18
P/S0,670,420,490,280,290,270,260,25
Udbytteprocent2,13 %2,37 %2,12 %3,18 %4,24 %4,24 %
Equity ratio24,20 %25,98 %26,81 %18,57 %23,81 %25,62 %27,73 %27,22 %
Gearing ratio182,94 %169,58 %158,85 %315,37 %213,72 %186,77 %160,49 %162,61 %

Kvartalsdata

Q2/22Q3/22Q4/222022Q1/23Q2/23eQ3/23eQ4/23e2023e
Omsætning173,70165,30188,36690,32187,90183,75173,74196,92742,31
EBITDA15,4018,0011,7854,4423,0020,2821,4818,4183,17
EBIT4,106,60-0,528,9810,507,388,385,1131,37
Overskud før skat2,504,60-2,861,587,504,835,632,3120,27
Netto indkomst1,763,29-0,759,585,502,983,341,2613,08